# 18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation

> **NCT03103490** · PHASE2 · TERMINATED · sponsor: **Stanford University** · enrollment: 45 (actual)

## Conditions studied

- Cardiac Sarcoidosis
- Myocardial Inflammation

## Interventions

- **DRUG:** 18F-FSPG

## Key facts

- **NCT ID:** NCT03103490
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-02
- **Primary completion:** 2021-09-28
- **Final completion:** 2021-09-28
- **Target enrollment:** 45 (ACTUAL)
- **Why stopped:** Loss of funding
- **Last updated:** 2023-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03103490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03103490, "18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03103490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*